Welcome!

News Feed Item

Concise Analysis of the International Regenerative Medicine Markets

DUBLIN, Feb. 4,2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xrndzp/regenerative) has announced the addition of the "Concise Analysis of the International Regenerative Medicine Markets" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new advancements in the ability to repair or replace damaged human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not), or a surgeon's skilled hands.

Now, the area of regenerative medicine promises to revolutionize humanity's ability to remediate countless physical maladies that have perpetually afflicted humans and other animals. Compared to a select few life forms--like the starfish--man-made solutions for tissue repair and organ replacement haven't come close to nature's solutions. And where there once was no solution even offered by nature, researchers are now at the cusp of overcoming such limitations by literally regrowing damaged tissue and restoring organ functions through the use of tissue engineering and stem cell therapy. This is the promise of regenerative medicine.

This report discusses the current state of regenerative medicine. The study provides a thorough overview of regenerative medicine sector together with analyses of the funding trends, intellectual property, market opportunities, therapeutic pipeline, research collaborations, partnership activities, and guidelines for establishing new ventures.

The report enables the reader gain in-depth knowledge about ongoing tissue engineering and stem cell therapy research programs carried out in universities and other research centers. Moreover, this analysis profiles the leading companies developing regenerative medicine solutions.

Key Topics Covered:

1. Overview

2. Regenerative Medicines: An Overview of Segments

3. Regenerative Medicine: The Next Evolution of Medical Treatment

4. Recent Advances in Regenerative Medicine and Stem Cell Research

5. Stem Cell Industry Highlights

6. Regenerative Medicines: A Brief Update from Selected Countries

7. Market Analysis for Regenerative Medicine Sector

8. Stem Cell Industry

9. Business Models and Requirements for a Successful Regenerative Medicine Industry

10. Company Profiles

Companies Mentioned:

  • Aastrom Biosciences, Inc.
  • Advanced Cell Technology, Inc. (ACT)
  • Aldagen, Inc.
  • Alseres Pharmaceuticals, Inc.
  • Altrika Ltd.
  • Amgen, Inc.
  • Amorcyte, Inc.
  • AnGes MG, Inc.
  • Angioblast Systems, Inc.
  • Angion Biomedica, Corp.
  • Ars Arthro Biotechnology, Inc.
  • Arteriocyte Medical Systems, Inc.
  • Athersys, Inc.
  • BIOMET
  • BeFutur Biotechnologies
  • BioE, Inc.
  • BioLine Rx
  • BioMimetic Therapeutics, Inc.
  • BioSafe Group SA
  • BioTime, Inc.
  • Bioheart, Inc.
  • Biovest International, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cardio BioSciences
  • CardioPolymer's Products
  • CardioPolymers, Inc.
  • Cardium Therapeutics, Inc.
  • CaridianBCT
  • Celgene Corporation
  • CellSeed, Inc.
  • Cellartis' Products
  • Cellerix
  • Celltrix
  • Cellular Dynamics International
  • Cerco Medical
  • Cook Biotech, Inc.
  • Cord Blood America (CBAI), Inc.
  • Cryo-Cell International, Inc.
  • Curis, Inc.
  • Cytori Therapeutics, Inc.
  • Develogen AG
  • Effector Cell Institute, Inc (ECI)
  • Epistem plc
  • FivePrime Therapeutics, Inc.
  • Forticell Bioscience, Inc.
  • Gamidia Cell Ltd.
  • GenVec, Inc.
  • GeneGrafts Ltd.
  • Genzyme Corporation
  • Geron Corporation
  • Harvest Technologies Corporation
  • HemaStem Therapeutics, Inc.
  • HepaLife Technologies, Inc.
  • Humacyte, Inc.
  • Hydra Biosciences, Inc.
  • Integra Lifesciences Holdings Corporation
  • Intercytex Group plc
  • International Stem Cell Corporation (ISCO)
  • Japan Tissue Engineering, Co., Ltd.
  • Karocell Tissue Engineering AB
  • Kensey Nash Corporation
  • Kiadis Pharma, BV
  • LifeCell
  • MaxCyte, Inc.
  • Mesoblast Ltd.
  • NanoCor's Products
  • NeuralStem, Inc.
  • NeuroNova AB
  • Olympus Terumo Biomaterials Corporation
  • Opexa Therapeutics, Inc.
  • Organogenesis, Inc.
  • Orthovita, Inc.
  • Osiris Therapeutics, Inc.
  • Osteotech, Inc.
  • Pervasis Therapeutics, Inc.
  • Pleuron's Technology
  • Pluristem Therapeutics, Inc.
  • ReNeuron Group plc
  • RegeneRx
  • Revivicor, Inc.
  • Saneron CCEL Therapeutics, Inc.
  • Sangamo BioSciences, Inc.
  • Stem Cell Innovations (SCI)
  • Stem Cell Sciences KK
  • StemCells, Inc.
  • SyntheMed, Inc.
  • Tengion
  • Thermogenesis Corp.
  • TiGenix
  • t cure GmbH

For more information visit http://www.researchandmarkets.com/research/xrndzp/regenerative

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists looked at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deliver...
After more than five years of DevOps, definitions are evolving, boundaries are expanding, ‘unicorns’ are no longer rare, enterprises are on board, and pundits are moving on. Can we now look at an evolution of DevOps? Should we? Is the foundation of DevOps ‘done’, or is there still too much left to do? What is mature, and what is still missing? What does the next 5 years of DevOps look like? In this Power Panel at DevOps Summit, moderated by DevOps Summit Conference Chair Andi Mann, panelists loo...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), provided an overview of various initiatives to certify the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldwide re...
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities. In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, posited that disruption is inevitable for comp...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
IoT solutions exploit operational data generated by Internet-connected smart “things” for the purpose of gaining operational insight and producing “better outcomes” (for example, create new business models, eliminate unscheduled maintenance, etc.). The explosive proliferation of IoT solutions will result in an exponential growth in the volume of IoT data, precipitating significant Information Governance issues: who owns the IoT data, what are the rights/duties of IoT solutions adopters towards t...
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, discussed some of the security challenges of the IoT infrastructure and related how these aspects impact Smart Living. The material was delivered interac...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
It is ironic, but perhaps not unexpected, that many organizations who want the benefits of using an Agile approach to deliver software use a waterfall approach to adopting Agile practices: they form plans, they set milestones, and they measure progress by how many teams they have engaged. Old habits die hard, but like most waterfall software projects, most waterfall-style Agile adoption efforts fail to produce the results desired. The problem is that to get the results they want, they have to ch...